Autoantibody to the proliferating cell nuclear antigen neutralizes the activity of the auxiliary protein for DNA polymerase delta

Two murine monoclonal antibodies to the proliferating cell nuclear antigen (PCNA), a rabbit anti-N-terminal peptide antibody and human auto-antibody to PCNA reacted with the auxiliary protein for DNA polymerase delta from fetal calf thymus following SDS-polyacrylamide gel electrophoresis, confirming the identity of PCNA and the auxiliary protein. Undenatured auxiliary protein was immunoprecipitated by the human autoantibody, but not by the monoclonal antibodies, which were raised to SDS-denatured PCNA, nor by the anti-N-terminal peptide antibody, suggesting that the epitopes recognized by both the monoclonal antibodies and the anti-peptide antibody are not exposed in the native protein. The human anti-PCNA autoantibody neutralized the activity of the auxiliary protein for DNA polymerase delta, but did not inhibit the activity of pol delta itself. The ability of pol delta to utilize template/primers containing long stretches of single-stranded template was inhibited by the anti-PCNA autoantibody, whereas the activity of pol alpha on such templates was not affected, confirming the specificity of the auxiliary protein for pol delta. The ability of PCNA, a cell cycle-regulated protein, to regulate the activity of pol delta suggests a central role for pol delta in cellular DNA replication.

The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation

The results are presented of allogeneic transplantation for 363 patients with acute non-lymphoblastic leukemia treated in Seattle from May 1973 through December 1985. The probabilities of surviving disease-free for 5 years for patients transplanted in first remission, in second remission, in untreated first relapse or in chemotherapy-resistant first relapse were 46%, 28%, 30%, and 21%, respectively. The corresponding probabilities of relapse within 5 years were 25%, 37%, 36% and 56%, respectively. Prognostic factors predictive of survival after marrow transplantation for patients transplanted in first remission included age, donor sex and the number of circulating blasts at the time of diagnosis. Acute graft-versus-host disease (GVHD) had a major adverse effect on survival, but chronic GVHD decreased the risk of relapse for patients transplanted in first remission.

Proliferating cell nuclear antigen/cyclin is an interleukin 2-responsive gene

Previously, we have shown that a protein designated p36 is synthesized at a high rate during interleukin 2-driven proliferation of a cloned T lymphocyte, L2. Biosynthesis of p36 increases 1000-fold during the initial mid-G1 phase of the cell cycle and remains high while the cells proliferate. In this report, we show that p36 has the same migration pattern by two-dimensional gel electrophoresis as proliferating cell nuclear antigen (PCNA)/cyclin and that antiserum to PCNA/cyclin selectively immunoprecipitates p36. In addition, by indirect immunofluorescence, PCNA/cyclin accumulates in the nucleus of interleukin 2-stimulated L2 cells during proliferation and is not detectable prior to the initial S phase or after proliferation ceases. These data indicate that PCNA/cyclin expression is induced by interleukin 2 and that PCNA/cyclin accumulation is closely associated with T lymphocyte proliferation.

Clinical mumps vaccine efficacy

From February 5 through April 23, 1982, 110 cases of mumps were reported among 357 students in a middle school in Ashtabula County, Ohio, an overall attack rate of 31%. Vaccine efficacy was calculated using a variety of case definitions, case surveillance systems, and vaccination-status ascertainment methods to evaluate their effects on the estimated vaccine efficacy. From data collected at the school for case ascertainment and vaccination status, clinical vaccine efficacy was initially estimated at 37%. By means of a uniform case definition (parotitis lasting two days or more) and only cases and vaccination status ascertained from parental questionnaires, estimated vaccine efficacy increased to 70%. From secondary attack rates in household members with provider-verified vaccination status, the vaccine efficacy further increased to 85%. This outbreak investigation confirms that the methods used to ascertain cases and determine vaccination status greatly affect estimates of vaccine efficacy. Studies relying solely on school records for case finding and determination of immunization status may provide misleadingly low estimates of vaccine efficacy for mumps vaccine as well as for other vaccines. Appropriate methods demonstrate that mumps vaccine is highly effective and support recommendations for its continued use.

Graft versus host disease-related secretory immunoglobulin A deficiency in bone marrow transplant recipients. Findings in labial saliva

Graft versus host disease-dependent decreases in salivary IgA levels were sought in labial gland saliva samples from bone marrow transplant recipients. Transplantation-associated, irradiation-related effects were also present, but these could be avoided if analyses were performed at 1 year or later after transplantation. Sampling of minor gland saliva eliminated the possibility of contamination with IgA-rich serum transudates arising from gingival or mucosal pathways which obscured results from previous studies using whole saliva samples. Patients with active extensive clinical disease had significantly depressed levels of salivary IgA. Since labial saliva is a principal source of total salivary IgA, the present findings may explain why patients with graft versus host disease are susceptible to infection via the sinobronchial portal.

Partial cDNA sequence of the gamma subunit of transducin

A 151 bp cDNA segment that encodes the amino-terminal portion of the gamma subunit of bovine transducin was isolated from a retinal cDNA library constructed in the expression vector lambda gt11. The base sequence of this cDNA confirms the sequence of the first 39 amino-terminal amino acids reported for the native protein (McConnell et al. (1984) Fed. Proc. 43, 1585). Northern blot analysis indicates that the complete mRNA is approximately 650 bases long and that its expression is limited to the retina.

Hypertrophied moderator band in atrial septal defect

A case of hypertrophied "moderator band" due to atrial septal defect is demonstrated on a resting thallium myocardial scan and a gated blood pool scan.

Demonstration of a polarizing signal that reverses future retinotectal patterns across Nuclepore filter barriers, in Xenopus embryonic eye

We have studied the interactions which occur in surgically disarranged eye rudiments by recombining a left anterior half-eye graft from a donor Xenopus embryo with a right host posterior half eye, across a variety of physical barriers, at embryonic stages 31 or 32. The anterior half-eye graft and barrier were removed 18 h later at stage 38, and the host posterior half-eye was allowed to reconstitute a whole eye whose visuotectal projection could be mapped electrophysiologically after metamorphosis. Anteroposteriorly reversed maps and double-anterior twinned maps that are characteristic of anterior half-eyes, were found in 50-65% of cases in each of the experimental series using no barrier (N = 16), or using Nuclepore filter barriers (N = 47), including 5 of 8 cases when a filter of 0.015 micrometer pore diameter was used. The latter cases are especially interesting, because the filter pores were much smaller than the minimum size known to permit cell-cell contact through the pores. No animals showed AP-reversed retinotectal maps or double-anterior twinned maps when the graft and host half-eyes were separated by a tantalum or plastic barrier (N = 21). Only a single case of AP-reversed mapping was found in 115 control animals including simple posterior half-eye preparations at stage 32 or 38 (N = 13), sham fusions (30 min) across Nuclepore filters (N = 35), or chronic application of a filter (or plastic or tantalum) barrier from stages 32-38 (N = 55) without a left anterior half-eye graft. We conclude that signals from an anterior half-eye can act to repolarize a posterior half-eye in the absence of cell transfer and under conditions which permit little or no direct cell-cell contact.

Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease

Four different murine monoclonal anti-T cell antibodies were administered to 15 patients with severe steroid resistant graft versus host disease (GVHD) in a phase I clinical trial in order to evaluate feasibility and toxicity. Antibodies 9.6 (IgG2a) and 35.1 (IgG2a) bind to separate epitopes on the E receptor (Tp50); antibody 10.2 (IgG2a) binds to the murine Lyt-1 homolog (Tp67); and antibody 12.1 (IgG2a) binds to a cell surface antigen with a molecular weight of approximately 100,000 daltons (Tp100). A total of 151 infusions were given, ranging in dose from one to 20 mg, each administered over a one to four hour period. One patient received a total of 259 mg of antibody over a period of 45 days. Six infusions (4%) in two patients were associated with fever or fever and chills. By decreasing the infusion rate, subsequent infusions to these two patients were accomplished without additional reactions. Although most of the patients treated with monoclonal antibodies required platelet support, the number of platelet units given was not significantly different from similar patients not receiving monoclonal antibodies. Six of ten patients receiving intermediate to high doses (5-20 mg) antibody therapy had evidence of at least partial improvement in GVHD in at least one involved organ system. None of the patients became immunized to mouse immunoglobulin. Our results suggest that therapy of GVHD with murine monoclonal anti-T cell antibodies is feasible and that these antibodies apparently can be administered to marrow transplant patients without significant toxicity. Further studies are required to determine which antibodies or combinations of antibodies have optimal anti-GVHD effect.

Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants

Although many patients who might benefit from therapeutic bone marrow transplantation lack HLA identical sibling donors, results from many centers now indicate that transplants involving donors other than identical siblings have been successful in a substantial number of cases. Most of these cases were selected because cells from the patient and donor were compatible in mixed lymphocyte culture. We have previously shown that the prediction of mixed lymphocyte culture nonreactivity by HLA-B,DR matching is far more successful if the matched donors shared antigen combinations known to possess significant positive linkage disequilibrium. We now also show that cells from donors with unrelated haplotypes having the specific DR determinants DR1, DR2, and DR3 are more likely than cells from donors with other haplotypes to be mutually compatible in mixed lymphocyte culture. However, even cells from donors with haplotypes with the highest levels of positive linkage disequilibrium frequently show significant mutual stimulation which can, in selected family studies, be attributed to determinants like SB that map between HLA-D/DR and GLO.

A qualitative and quantitative ultrastructural study of glial cells in the developing visual cortex of the rat

(i) This paper provides new information on the time course and fine structural features of glial cell differentiation, on the relative frequencies of glioblasts, astroblasts, astrocytes, oligodendrocytes and microglial cells, and on neuron: glia ratios in visual cortex of the rat between birth and maturity. The analyses were done on montages of electron micrographs of 75 pm wide strips extending the full depth of the cortex from animals 12 h and 4, 6, 8, 10, 12, 14, 20, 24, 90 and 180 days old (six montages from two or three animals at each age). (ii) At birth, and up to 4 days, most non-neuronal cells are poorly differentiated, irregularly shaped cells with dark nuclei (glioblasts). A few at this stage and progressively larger numbers over the next few days, can be recognized asastroblastsby the presence of a distinctive form of granular reticulum (distended cisterns with a moderately electron dense content), and some also by their position in contact with the subpial or perivascular basal laminae. Astroblasts enlarge, develop processes and transform into immature astrocytes: their nuclei become paler, the granular reticulum is no longer distended, and glial filaments begin to accumulate.Mature astrocyteswith pale nuclei, filaments and a low concentration of perikaryal organelles in a pale cytoplasmic matrix predominate at 24 days, and at 3-6 months 51 % of all glial cells are astrocytes. (iii) Concentrations of glioblasts (at 0 and 4 days) and subsequently of cells of the astrocytic lineage are apparent in the most superficial and in the deepest cortical layers, and an additional small peak is seen at the level of layer IV in the adult animals. The superficial concentration is probably associated with the subpial glia limitans and the layer IV concentration with the high density of synapses in this region; several probable explanations are considered for the concentration in layer VI. (iv) Processes ofradial glial cellsare apparent from birth to day 8 but not thereafter. No evidence was found for transformation of radial glia into astrocytes. A peak in phagocytic activity by immature microglial cells at days 6-8 suggests the possibility of loss of radial glial processes by degeneration rather than transformation. (v)Oligodendroblasts, intermediate in morphology between glioblasts and light oligodendrocytes, appear suddenly in the deep cortex and subcortical white matter at day 6 and are rapidly replaced bylight oligodendrocytes. These are large, organelle-rich cells with characteristically distended Golgi saccules, and are the only oligodendrocytes present during early myelination, which begins at day 10. Early in the 3rd postnatal week some light oligodendrocytes are replaced bymedium oligodendrocytes, which are smaller and darker, with abundant orderly stacks of granular reticulum.Dark oligodendrocytesare first apparent at the end of the 3rd week, account for about one-third of all oligodendrocytes at day 24, predominate at day 40 and constitute 90 % of all oligodendrocytes at 3 and 6 months, at which time oligodendrocytes comprise 39% of all cortical glial cells. We suggest that the progression from light to medium oligodendrocytes does not simply represent a diminution in the overall level of synthetic activity but that different components of the myelin sheath are being synthesized at the two stages. (vi)Microgliaare present from birth but are seen in significant numbers at days 6—10 and thereafter. Some are relatively mature in appearance, even in the youngest animals, and almost all are similar to the resting microglia of adult brain by day 16. At 3-6 months, 8 % of all cortical glial cells are identified as microglia and these cells are fairly evenly distributed throughout the cortical depth but are surprisingly and consistently poorly represented in layer VI. From day 6 to the end of the 2nd postnatal week, cells with poorly differentiated cytoplasm (many free polyribosomes), but containing phagocytosed products of cell degeneration, are identified asimmature microglia. However, it is possible that such cells do not mature into classical resting microglia but that they represent a different cell type. (vii) Theneuron: glia ratiois 4.54 at birth, rises to 5.09 at 4 days, and falls to approximately 2.5 at days 12-24. At 3-6 months the ratio is 2.13.

Gynecologic manifestations of chronic graft-versus-host disease

Gynecologic manifestations of the clinicopathologic syndrome known as graft-versus-host disease seen in 5 patients treated with allogeneic bone transplantation are presented. The clinical symptoms and significant problems found in association with graft-versus-host disease may include extensive sclerosing vaginitis and stricture formation. Treatment and possible preventive therapy are discussed.

Depolymerization of dendritic microtubules following incubation of cortical slices

Electron microscopical examination indicated that incubation of slices of rat cerebral cortex in Krebs buffer at room temperature of 37 degrees C led to a rapid and more or less complete depolymerization of dendritic microtubules. The loss of dendritic microtubules did not appear to be a consequence of anoxia. Myelinated axons showed only a partial loss of microtubules and the microtubules of preterminal axons were unaffected by incubation. These results indicate differential labilities of axonal and dendritic microtubules under these conditions of incubation. Such an effect of the incubation of slices in Krebs buffer indicates a need for caution in the interpretation of experiments on slice preparations.

A convenient culture chamber for observation and embedding of macrophage monolayers for transmission electron microscopy

A chamber adapted from a polypropylene test tube is described for the cultivation and processing of undisturbed monolayers of normal mouse macrophages for transmission electron microscopy (TEM). Peritoneal exudate cells are grown in the chambers on Visking dialysis membranes pretreated with Polybrene (Sigma Chemical Co.) and normal mouse serum. The cells are not further disturbed after adherence since the entire chamber, including dialysis membrane and cells, is processed for electron microscopy using standard material and protocols and the embedded dialysis membrane is readily oriented and thin-sectioned. This method is efficient for studying adherent cells since growth can be nearly confluent and cells remain firmly attached throughout the manipulations. Since a transparent membrane is used, cells can also be observed with the light microscope at all stages prior to sectioning.

Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients

Sixty-five multiply transfused patients with severe aplastic anemia were given cyclophosphamide followed by grafts anemia were given cyclophosphamide followed by grafts from HLA-identical siblings. The effect of the administration of viable donor buffy coat cells following the marrow inoculum was evaluated with regard to graft rejection and survival. Results in 43 patients so treated are presented along with those in 22 concurrent patients given marrow alone. Most patients given buffy coat had positive in vitro tests of sensitization indicating a high risk for graft rejection, while all but one of the patients given marrow alone had negative tests. Thirty of the 43 (70%) patients given marrow and buffy coat are alive between 10 and 61 mo (median 36) after grafting; 4 died after graft rejection and 6 with acute or chronic graft-versus-host disease (GVHD). Eleven of the 22 (50%) patients given marrow alone are alive between 29 and 65 mo (median 52); 7 died after graft rejection and 3 with GVHD. The addition of buffy coat cell infusions to the marrow inoculum reduced the risk of rejection and increased survival in the currently reported transfused patients when compared to patients grafted before 1976. However, there was an increased risk of chronic GVHD. Recipients of marrow from female donors survived slightly better (73%) than recipients of male marrow (58%).